Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism DDX53 inhibitors(DEAD-box helicase 53 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | KR | 11 Mar 2024 | |
Non-Small Cell Lung Cancer | Preclinical | CN | 16 Apr 2023 |